WASHINGTON—Sabinsa Corp.’s New Dietary Ingredient (NDI) notification forSelenoForce®, a selenium-enriched garlic product manufactured by a patent-pending soilless culture process, to FDA was accepted and filed. The selenium-enriched bulbs are dried, powdered and standardized to yield SelenoForce containing 1,000 ppm selenium, in bioavailable organic form, in a base of natural garlic powder.
